Frequency of the dawn phenomenon in type 2 diabetes: Implications for diabetes therapy

Diabetes Technology and Therapeutics

Volumn 4, Issue 5, 2002, Pages 595-605

  Carroll, Mary F ^a   Hardy, Kevin J ^a   Burge, Mark R ^a   Schade, David S ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; C PEPTIDE; GLIPIZIDE; GLUCAGON; GROWTH HORMONE; HEMOGLOBIN A1C; HYDROCORTISONE; INSULIN; ISOPHANE INSULIN; NORADRENALIN; ORAL ANTIDIABETIC AGENT;

ADRENALIN BLOOD LEVEL; ADULT; AGED; ARTICLE; BODY MASS; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG INFUSION; FEMALE; GLUCAGON BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE RELEASE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN TREATMENT; MALE; MORNING HYPERGLYCEMIA; NON INSULIN DEPENDENT DIABETES MELLITUS; NORADRENALIN BLOOD LEVEL; PREVALENCE; PRIORITY JOURNAL; TREATMENT OUTCOME;

BLOOD GLUCOSE; CIRCADIAN RHYTHM; DIABETES MELLITUS, TYPE 2; FEMALE; HORMONES; HUMAN GROWTH HORMONE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED;

EID: 0036412966     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/152091502320798213     Document Type: Article

References (35)

1. Schmidt MI, Hadji-Georgopulos A, Rendell M, Margolis S, Kowarski A: The dawn phenomenon, an early morning glucose rise: Implications for diabetic intraday blood glucose variation. Diabetes Care 1981;4:579-585.
2. Perriello G, De Feo P, Torlone E, Fanelli C, Santeusanio F, Brunetti P, Bolli GB: The dawn phenomenon in type 1 (insulin-dependent) diabetes mellitus: Magnitude, frequency, variability, and dependency on glucose counterregulation and insulin sensitivity. Diabetologica 1991;34:21-28.
3. Edge JA, Matthews DR, Dunger DB: The dawn phenomenon is related to overnight growth hormone release in adolescent diabetics. Clin Endocrinol 1990;33:729-737.
4. Kobayashi K, Ameniya S, Sawanobori E, Higashida K, Ishihara T, Kobayashi K, Kato K, Nakazawa S: Role of IGF binding protein-1 in the dawn phenomenon and glycemic control in children and adolescents with IDDM. Diabetes Care 1997;20:1442-1447.
5. Bolli GB, Gerich JE: The "dawn phenomenon" - A common occurrence in both non-insulin-dependent and insulin-dependent diabetes mellitus. N Engl J Med 1984;310:746-750.
6. Atiea JA, Ryder RR, Vora J, Owens DR, Luzio SD, Williams S, Hayes TM: Dawn phenomenon: Its frequency in non-insulin-dependent diabetic patients on conventional therapy. Diabetes Care 1987;10:461-465.
7. Atiea JA, Vora JP, Owens DR, Luzio S, Read GF, Walker RF, Hayes TM: Non-insulin-dependent diabetic patients (NIDDMs) do not demonstrate the dawn phenomenon at presentation. Diabetes Res Clin Pract 1988;5:37-44.
8. Ohneda A, Kobayashi T, Nihei J, Iwasa S, Kondo K: Measurement of glucagons in human plasma by enzyme immunoassay. J Immunoassay 1983;4:339-349.
9. Shah SD, Clutter WE, Cryer PE: External and internal standards in the single isotope derivative (radioenzymatic) assay of plasma norepinephrine and epinephrine in normal humans and persons with diabetes mellitus or chronic renal failure. J Lab Clin Med 1985;106:624-629.
10. Atiea JA, Luzio S, Owens DR: The dawn phenomenon and diabetes control in treated NIDDM and IDDM patients. Diabetes Res Clin Pract 1992;16:183-190.
11. Brennan JR, Gebhart SSP, Blackard WG: Pump-induced insulin aggregation: A problem with the Biostator. Diabetes 1985;34:353-359.
12. Tordjman KM, Havlin CE, Levandoski LA, White NH, Santiago JV, Cryer PE: Failure of nocturnal hypoglycemia to cause fasting hyperglycemia in patients with insulin-dependent diabetes mellitus. N Engl J Med 1987;317:1552-1559.
13. Stephenson JM, Schernthaner G: Dawn phenomenon and the Somogyi effect in IDDM. Diabetes Care 1989,12:245-251.
14. Hirsch IB, Smith LJ, Havlin CE, Shah SD, Clutter WE, Cryer PE: Failure of nocturnal hypoglycemia to cause daytime hyperglycemia in patients with IDDM. Diabetes Care 1990;13:133-142.
15. Raskin P: The Somogyi phenomenon: Sacred cow or bull? Arch Intern Med 1984;144:781-787.
16. De Feo P, Perriello G, Ventura MM, Calcinaro F, Basta G, Lolli C, Cruciani C, Dell'olio A, Santeusanio F, Brunetti P, Bolli GB: Studies on overnight insulin requirements and metabolic clearance rate of insulin in normal and diabetic man: Relevance to the pathogenesis of the dawn phenomenon. Diabetologica 1986;29:475-480.
17. Boden G, Ruiz, Urbain JL, Chen X: Evidence for a circadian rhythm of insulin secretion. Am J Physiol 1996;271:E246-E252.
18. Trumper BG, Reschke K, Molling J: Circadian variation of insulin requirement in insulin dependent diabetes mellitus. The relationship between circadian changes in insulin demand and diurnal patterns of growth hormone, cortisol and glucagon during euglycemia. Horm Metab Res 1995;27:141-147.
19. Beaufrere B, Beylot M, Metz C, Ruitton A, Francois R, Riou JP, Mornex R: Dawn phenomenon in type 1 (insulin-dependent) diabetic adolescents: Influence of nocturnal growth hormone secretion. Diabetologica 1988;31:607-611.
20. Kerner W, Navascues I, Torres AA, Pfeiffer EF: Studies on the pathogenesis of the dawn phenomenon in insulin-dependent diabetic patients. Metabolism 1984;33:458-464.
21. Perrriello G, De Feo P, Torlone E, Fanelli C, Fanteusanio F, Brunetti P, Bolli GB: Nocturnal spikes of growth hormone secretion cause the dawn phenomenon in type 1 (insulin-dependent) diabetes mellitus by decreasing hepatic (and extrahepatic) sensitivity to insulin in the absence of insulin waning. Diabetologica 1990;33:52-59.
22. Edge JA, Matthews DR, Dunger DB: The dawn phenomenon is related to overnight growth hormone release in adolescent diabetics. Clin Endocrinol 1990;33:729-737.
23. Campbell PJ, Bolli GB, Cryer PE, Gerich JE: Sequence of events during development of the dawn phenomenon in insulin-dependent diabetes mellitus. Metabolism 1985;34:1100-1104.
24. Boyle PJ, Avogaro A, Smith L, Shah SD, Cryer PE, Santiago JV: Absence of the dawn phenomenon and abnormal lipolysis in type 1 (insulin-dependent) diabetic patients with chronic growth hormone deficiency. Diabetologica 1992;35:373-379.
25. Campbell PF, Bolli GB, Gerich JE: Prevention of the dawn phenomenon (early morning hyperglycemia) in insulin-dependent diabetes mellitus by bedtime intranasal administration of a long-acting somatostatin analog. Metabolism 1988;37:34-37.
26. Moller N, Jorgensen JO, Moller J, Orskov L, Ovesen P, Schmitz O, Christiansen JS, Orskov H: Metabolic effects of growth hormone in humans. Metabolism 1995;44(10 Suppl 4):33-36.
27. MacGorman LR, Rizza RA, Gerich JE: Physiological concentrations of growth hormone exert insulin-like and insulin antagonistic effects on both hepatic and extrahepatic tissues in man. J Clin Endocrinol Metab 1981;53:556-559.
28. Moller N, Jorgensen JO, Abildgard N, Orskov L, Schmitz O, Christiansen JS: Effects of growth hormone on glucose metabolism. Horm Res 1991;36(Suppl 1):32-35.
29. Kollind M, Adamson U, Lins PE, Curstedt T: Importance of growth hormone for blood glucose regulation following insulin-induced nocturnal hypoglycemia in insulin-dependent diabetes mellitus. Acta Med Scand 1988;223:159-164.
30. Levy CJ, Kinsley BT, Bajaj M, Simonson DC: Effect of glycemic control on glucose counterregulation during hypoglycemia in NIDDM. Diabetes Care 1998;21:1330-1338.
31. Silvestri R, Lasco A, Marabello M, Puglisi RM, Casella C, Cucinotta D, Manganaro O, Frisina N, Di Perri R: Wake and sleep cardiovascular reflexes and GH profiles in diabetic patients. Acta Diabetol Lat 1989;26:237-244.
32. Martina V, Bruno G, Tagliabue M, Bertaina S, Maccario M, Grottoli S, Procopio M, Ozzello A, Camanni F: Blunted GH response to growth hormone-releasing hormone (GHRH) alone or combined with arginine in non-insulin-dependent diabetes mellitus. Horm Metab Res 1995;27:26-30.
33. Micic M, Macut D, Popovic V, Kendereski A, Sumarac-Dumanovic M, Zoric S, Dieguez C, Casaneuva FF: Growth hormone (GH) response to GH-releasing peptide-6 and GH-releasing hormone in normal-weight and overweight patients with non-insulin-dependent diabetes mellitus. Metabolism 1999;48:525-530.
34. Franek E, Schaefer F, Bergis K, Feneberg R, Ritz E: Abnormal pulsatile secretion of growth hormone in non-insulin-dependent diabetes mellitus. Clin Endocrinol (Oxf) 1997;47:471-478.
35. Maran A, Crepaldi C, Tiengo A, Grassi G, Vitali E, Pagano G, Bistoni S, Calabrese G, Santeusanio F, Leonetti F, Ribaudo M, Di Mario U, Annuzzi G, Genovese S, Riccardi G, Previti M, Cucinotta D, Giorgino F, Bellomo A, Giorgino R, Poscia A, Varalli M: Continuous subcutaneous glucose monitoring in diabetic patients: A multicenter analysis. Diabetes Care 2002;25:347-352.